tiprankstipranks
Trending News
More News >
Insight Molecular Diagnostics (IMDX)
NASDAQ:IMDX
US Market

Insight Molecular Diagnostics (IMDX) Ownership - Who Owns Insight Molecular Diagnostics?

Compare
430 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Feb 12, 2026
xxxxxxxxxxxxx
$2999999

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
23,863,835Insider74.19%129,580,624
419,719Institution1.30%2,279,074
385,202Institution1.20%2,091,647
201,231Insider0.63%1,092,684
193,433Institution0.60%1,050,341
52,447Insider0.16%284,787
44,378Institution0.14%240,973
39,509Insider0.12%214,534
36,564Insider0.11%198,543
29,602Institution0.09%160,739

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
385,202Institution1.20%2,091,647
193,433Institution0.60%1,050,341
2,066Institution<0.01%11,218

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
220,580Institution0.69%1,438,182
199,139Institution0.62%1,298,386
29,222Institution0.09%166,273

FAQ

Who Owns Insight Molecular Diagnostics (IMDX)?
Currently, no data Available
What percentage of Insight Molecular Diagnostics (IMDX) stock is held by institutional investors?
Currently, no data Available
What percentage of Insight Molecular Diagnostics (IMDX) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Insight Molecular Diagnostics (IMDX)?
Broadwood Partners Lp owns the most shares of Insight Molecular Diagnostics (IMDX).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.